IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis

Mi Kyung Park, Yang Mi Her, Mi La Cho, Hye Joa Oh, Eun Mi Park, Seung Ki Kwok, Ji Hyeon Ju, Kyung Su Park, Do Sik Min, Ho Youn Kim, Sung Hwan Park

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Osteoclastogenesis plays an important role in joint destruction in rheumatoid arthritis (RA). IL-15 is a pleiotropic proinflammatory cytokine that appears to help mediate the pathological bone loss. This study was undertaken to explore the signaling molecules essential for osteoclastogenesis mediated by IL-15 in rheumatoid synovial fibroblasts. Expression of phospholipase D1 (PLD1) and osteoclast-related gene expression in synovial tissues and their modulation by treatment with IL-15 and different inhibitors in synovial fibroblasts of RA patients were evaluated using immunohistochemistry and quantitative polymerase chain reaction. The levels of IL-15 in serum and synovial fluid were measured by ELISA. The effects of IL-15 and phosphatidic acid (PA) on osteoclast formation were evaluated in cocultures of rheumatoid synovial fibroblasts and peripheral blood monocytes or monocytes alone in the presence of M-CSF and RANKL. The levels of RANKL and PLD1 but not PLD2 were upregulated significantly by IL-15, and the RANKL level was significantly upregulated by PA in rheumatoid synovial fibroblasts. Blocking PA production with 1-butanol and siRNA against PLD1 significantly inhibited the IL-15-stimulated expression of RANKL and PLD1. IL-15 levels were significantly higher in serum and synovial fluid from patients with RA than in osteoarthritis patients and healthy controls. IL-15 and PA induced osteoclast formation through the mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathways. Activation of PLD1 contributes to IL-15-mediated osteoclastogenesis via the MAPKs and NF-κB signaling pathways in rheumatoid synovial fibroblasts. Our data suggest that PLD1 might be an efficient therapeutic strategy for preventing bone destruction in rheumatoid arthritis.

Original languageEnglish
Pages (from-to)42-51
Number of pages10
JournalImmunology Letters
Volume139
Issue number1-2
DOIs
Publication statusPublished - 2011 Sep 30

Fingerprint

Interleukin-15
Osteogenesis
Rheumatoid Arthritis
Phosphatidic Acids
Fibroblasts
Osteoclasts
Proto-Oncogene Proteins c-akt
Synovial Fluid
Mitogen-Activated Protein Kinases
Monocytes
1-dodecylpyridoxal
Bone and Bones
1-Butanol
Macrophage Colony-Stimulating Factor
Coculture Techniques
Serum
Osteoarthritis
Small Interfering RNA
phospholipase D1
Joints

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Park, M. K., Her, Y. M., Cho, M. L., Oh, H. J., Park, E. M., Kwok, S. K., ... Park, S. H. (2011). IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Immunology Letters, 139(1-2), 42-51. https://doi.org/10.1016/j.imlet.2011.04.013
Park, Mi Kyung ; Her, Yang Mi ; Cho, Mi La ; Oh, Hye Joa ; Park, Eun Mi ; Kwok, Seung Ki ; Ju, Ji Hyeon ; Park, Kyung Su ; Min, Do Sik ; Kim, Ho Youn ; Park, Sung Hwan. / IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. In: Immunology Letters. 2011 ; Vol. 139, No. 1-2. pp. 42-51.
@article{63286d6eb80a421ea7f5dc2fa071aeea,
title = "IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis",
abstract = "Osteoclastogenesis plays an important role in joint destruction in rheumatoid arthritis (RA). IL-15 is a pleiotropic proinflammatory cytokine that appears to help mediate the pathological bone loss. This study was undertaken to explore the signaling molecules essential for osteoclastogenesis mediated by IL-15 in rheumatoid synovial fibroblasts. Expression of phospholipase D1 (PLD1) and osteoclast-related gene expression in synovial tissues and their modulation by treatment with IL-15 and different inhibitors in synovial fibroblasts of RA patients were evaluated using immunohistochemistry and quantitative polymerase chain reaction. The levels of IL-15 in serum and synovial fluid were measured by ELISA. The effects of IL-15 and phosphatidic acid (PA) on osteoclast formation were evaluated in cocultures of rheumatoid synovial fibroblasts and peripheral blood monocytes or monocytes alone in the presence of M-CSF and RANKL. The levels of RANKL and PLD1 but not PLD2 were upregulated significantly by IL-15, and the RANKL level was significantly upregulated by PA in rheumatoid synovial fibroblasts. Blocking PA production with 1-butanol and siRNA against PLD1 significantly inhibited the IL-15-stimulated expression of RANKL and PLD1. IL-15 levels were significantly higher in serum and synovial fluid from patients with RA than in osteoarthritis patients and healthy controls. IL-15 and PA induced osteoclast formation through the mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathways. Activation of PLD1 contributes to IL-15-mediated osteoclastogenesis via the MAPKs and NF-κB signaling pathways in rheumatoid synovial fibroblasts. Our data suggest that PLD1 might be an efficient therapeutic strategy for preventing bone destruction in rheumatoid arthritis.",
author = "Park, {Mi Kyung} and Her, {Yang Mi} and Cho, {Mi La} and Oh, {Hye Joa} and Park, {Eun Mi} and Kwok, {Seung Ki} and Ju, {Ji Hyeon} and Park, {Kyung Su} and Min, {Do Sik} and Kim, {Ho Youn} and Park, {Sung Hwan}",
year = "2011",
month = "9",
day = "30",
doi = "10.1016/j.imlet.2011.04.013",
language = "English",
volume = "139",
pages = "42--51",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "1-2",

}

Park, MK, Her, YM, Cho, ML, Oh, HJ, Park, EM, Kwok, SK, Ju, JH, Park, KS, Min, DS, Kim, HY & Park, SH 2011, 'IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis', Immunology Letters, vol. 139, no. 1-2, pp. 42-51. https://doi.org/10.1016/j.imlet.2011.04.013

IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. / Park, Mi Kyung; Her, Yang Mi; Cho, Mi La; Oh, Hye Joa; Park, Eun Mi; Kwok, Seung Ki; Ju, Ji Hyeon; Park, Kyung Su; Min, Do Sik; Kim, Ho Youn; Park, Sung Hwan.

In: Immunology Letters, Vol. 139, No. 1-2, 30.09.2011, p. 42-51.

Research output: Contribution to journalArticle

TY - JOUR

T1 - IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis

AU - Park, Mi Kyung

AU - Her, Yang Mi

AU - Cho, Mi La

AU - Oh, Hye Joa

AU - Park, Eun Mi

AU - Kwok, Seung Ki

AU - Ju, Ji Hyeon

AU - Park, Kyung Su

AU - Min, Do Sik

AU - Kim, Ho Youn

AU - Park, Sung Hwan

PY - 2011/9/30

Y1 - 2011/9/30

N2 - Osteoclastogenesis plays an important role in joint destruction in rheumatoid arthritis (RA). IL-15 is a pleiotropic proinflammatory cytokine that appears to help mediate the pathological bone loss. This study was undertaken to explore the signaling molecules essential for osteoclastogenesis mediated by IL-15 in rheumatoid synovial fibroblasts. Expression of phospholipase D1 (PLD1) and osteoclast-related gene expression in synovial tissues and their modulation by treatment with IL-15 and different inhibitors in synovial fibroblasts of RA patients were evaluated using immunohistochemistry and quantitative polymerase chain reaction. The levels of IL-15 in serum and synovial fluid were measured by ELISA. The effects of IL-15 and phosphatidic acid (PA) on osteoclast formation were evaluated in cocultures of rheumatoid synovial fibroblasts and peripheral blood monocytes or monocytes alone in the presence of M-CSF and RANKL. The levels of RANKL and PLD1 but not PLD2 were upregulated significantly by IL-15, and the RANKL level was significantly upregulated by PA in rheumatoid synovial fibroblasts. Blocking PA production with 1-butanol and siRNA against PLD1 significantly inhibited the IL-15-stimulated expression of RANKL and PLD1. IL-15 levels were significantly higher in serum and synovial fluid from patients with RA than in osteoarthritis patients and healthy controls. IL-15 and PA induced osteoclast formation through the mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathways. Activation of PLD1 contributes to IL-15-mediated osteoclastogenesis via the MAPKs and NF-κB signaling pathways in rheumatoid synovial fibroblasts. Our data suggest that PLD1 might be an efficient therapeutic strategy for preventing bone destruction in rheumatoid arthritis.

AB - Osteoclastogenesis plays an important role in joint destruction in rheumatoid arthritis (RA). IL-15 is a pleiotropic proinflammatory cytokine that appears to help mediate the pathological bone loss. This study was undertaken to explore the signaling molecules essential for osteoclastogenesis mediated by IL-15 in rheumatoid synovial fibroblasts. Expression of phospholipase D1 (PLD1) and osteoclast-related gene expression in synovial tissues and their modulation by treatment with IL-15 and different inhibitors in synovial fibroblasts of RA patients were evaluated using immunohistochemistry and quantitative polymerase chain reaction. The levels of IL-15 in serum and synovial fluid were measured by ELISA. The effects of IL-15 and phosphatidic acid (PA) on osteoclast formation were evaluated in cocultures of rheumatoid synovial fibroblasts and peripheral blood monocytes or monocytes alone in the presence of M-CSF and RANKL. The levels of RANKL and PLD1 but not PLD2 were upregulated significantly by IL-15, and the RANKL level was significantly upregulated by PA in rheumatoid synovial fibroblasts. Blocking PA production with 1-butanol and siRNA against PLD1 significantly inhibited the IL-15-stimulated expression of RANKL and PLD1. IL-15 levels were significantly higher in serum and synovial fluid from patients with RA than in osteoarthritis patients and healthy controls. IL-15 and PA induced osteoclast formation through the mitogen-activated protein kinases (MAPKs) and NF-κB signaling pathways. Activation of PLD1 contributes to IL-15-mediated osteoclastogenesis via the MAPKs and NF-κB signaling pathways in rheumatoid synovial fibroblasts. Our data suggest that PLD1 might be an efficient therapeutic strategy for preventing bone destruction in rheumatoid arthritis.

UR - http://www.scopus.com/inward/record.url?scp=79960700295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960700295&partnerID=8YFLogxK

U2 - 10.1016/j.imlet.2011.04.013

DO - 10.1016/j.imlet.2011.04.013

M3 - Article

C2 - 21620893

AN - SCOPUS:79960700295

VL - 139

SP - 42

EP - 51

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 1-2

ER -